[Risks of prostaglandin treatment of tubal pregnancy].
Lippert
T H
TH
Korte
K
K
Dietl
J
J
D015237:Dinoprost / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D011247:Pregnancy; D011274:Pregnancy, Tubal / Q000188:drug therapy*; D012307:Risk Factors
D015237:Dinoprost
Uber die Risiken einer Prostaglandin-Behandlung der Tubargravidität.